57
Participants
Start Date
November 30, 2006
Primary Completion Date
March 31, 2007
Study Completion Date
June 30, 2007
Placebo
Two matching placebo tablets were administered every day over 2 weeks with a 2-day break for the week-end.
rBet v 1
Two tablets (1 placebo + 1 rBet v 1 or 2 rBet v 1) were administered every day over 2 weeks with a 2-day break for the week-end. Administered doses ranged from 50 to 300 µg rBet v 1.
National University Hospital - Allergy Unit 4222, Copenhagen
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Stallergenes Greer
INDUSTRY